References
- Peppercorn MA. Sulfasalazine and related new drugs. J Gin Pharmacol 1987; 27: 260–266
- Minocha A, Dean HA, Jr, Mayle JE. Acute sulfasalazine overdose. J Toxicol Clin Toxicol 1991; 29: 543–551
- Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 1985; 10: 285–302
- Bartels P D, Lund-Jacobsen H. Blood lactate and ketone body concentrations in salicylate intoxication. Hum Toxicol 1986; 5: 363–366
- Gabay C, De Bandt M, Palazzo E. Sulphasalazine-related life-threatening side effects: IsN-acetylcysteine of therapeutic value. Clin Exp Rheumatol 1993; 11: 417–420
- Gray T A, Buckley B M, Vale JA. Hyperlactataemia and metabolic acidosis following paracetamol overdose. Q J Med 1987; 246: 811–821
- Flanagan R J, Mant TG. Coma and metabolic acidosis earlv in severe acute paracetamol Doisonine. Hum Toxicol 1986; 5: 179–182
- Curry S. Methemoglobinemia. Ann Emerg Med 1982; 11: 214–221
- Koel M, Nebinger P. Specificity data of the salicylate assay by fluorescent polarization immunoassay. J Anal Toxicol 1989; 13: 358–360
- Tredger JM, Thuluvath P, Williams R, Murray-Lyon IM. Metabolic basis for high paracetamol dosage without hepatic injury: A case study. Hum Exp Toxicol 1995; 14: 8–12
- Block R, Jankowski J A, Lacoux P, Pennington CR. Does hypothermia protect against the development of hepatitis in paracetamol overdose. Anaesthesia 1992; 47: 789–791
- Pronai L, Yukinobu I, Lang I, Feher J. The oxygen-centered radicals scavenging activity of sulfasalazine and its metabolites. A direct protection of the bowel. Acta Physiol Hung 1992; 80: 317–323